Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                News & Events for Human Drugs

News & Events for Human Drugs

                        CDER Conversations
          Q&A with FDA
          Spotlight on CDER Science


                        From Our Perspective Home
          Drugs
          News & Events for Human Drugs
          What's New Related to DrugsNews & Events for Human Drugs What's New Related to Drugs
  
  	
    Subscribe to Email Updates
    Share
    Post
    Linkedin

    Email
    PrintMore Email Subscriptions Related to DrugsRSS Feed for This Page

**Updated Monday through Friday**

Drug Firm Annual Registration Status
	Drug Firm Annual Registration Status Download File
	National Drug Code Directory
	NDC Unfinished Drugs Excluded Database File
	NDC Database Excluded Packages and Products
	Wholesale Distributor and Third-Party Logistics Providers Reporting**January 30, 2024**

Public Notifications:
	Arize contains hidden drug ingredient
		Updated: Schwinnng contains hidden drug ingredient
		Updated: Sustain® contains hidden drug ingredients
	Drug Trials Snapshots: REZLIDHIA
	Drugs@FDA Data Files (Updated)
	Chinese Drug Safety Communication: 美國食品藥物管理局對服用批准用於2型糖尿病和肥胖症的某種藥物的患者的自殺念頭或行為報告的持續評估更新 初步評估未提示因果關係
	Comunicado de seguridad de la FDA: Actualización sobre la evaluación en curso de la FDA de los informes de pensamientos o acciones suicidas en pacientes que toman cierto tipo de medicamentos aprobados para la diabetes tipo 2 y la obesidad
	FDA Drug Shortages
	Erythromycin Ointment (New - Currently in Shortage)
		Triazolam Tablet (New - Discontinuation)**January 29, 2024**

FDA revises letter of authorization for the emergency use authorization for Paxlovid
	Draft Guidance: Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products**January 26, 2024**

FDA Drug Shortages

	I.V. Fat Emulsion (Updated - Resolved)
		Zolpidem Tartrate Tablet, Extended Release (New - Discontinuation)**January 24, 2024**

FDA Drug Shortages

	Lisdexamfetamine Dimesylate Capsule (Updated - Currently in Shortage)
		Lidocaine Hydrochloride Solution (New - Currently in Shortage)
		Methylphenidate Hydrochloride Tablet, Extended Release (Updated - Currently in Shortage)
	Final Guidance: Revising ANDA Labeling Following Revision of the RLD Labeling Guidance for Industry**January 23, 2024**

Webinar: Expanding Generic Drug Access Through International Engagements
	FDA's ISTAND Pilot Program accepts submission of first artificial intelligence-based and digital health technology for neuroscience
	Drugs@FDA Data Files (Updated)
	Drug Trials Snapshot: NEXOBRID
	FDA Drug Shortages
	Capecitabine Tablet (Updated - Discontinuation)
		Dexamethasone Sodium Phosphate Injection (Updated - Currently in Shortage)
		Liraglutide Injection (Updated - Currently in Shortage)
		Somatropin Injection (Updated - Currently in Shortage)**January 22, 2024**

Activities Report of the Generic Drug Program | FDARA Title VIII Sections 807 and 805 (Updated)
	FDA Drug Shortages
	Amoxicillin Powder, For Suspension (Updated - Currently in Shortage)
		Conivaptan Hydrochloride Injection (Updated - Discontinuation)
		Heparin Sodium Injection (Updated - Currently in Shortage)
		Rocuronium Bromide Injection (Updated - Currently in Shortage)**January 19, 2024**

FDA approves erdafitinib for locally advanced or metastatic urothelial carcinoma
	Drug Safety Communication: FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab)
	FDA Drug Shortages
	Sodium Bicarbonate Injection (Updated - Currently in Shortage)**January 17, 2024**

CDERLearn Training and Education (updated)
	FDA announces shelf-life extension for naloxone nasal spray
	Q&A with FDA Podcast Series offering Continuing Education (CE) Credits 
	A Step Forward in the Treatment of Opioid and Alcohol Dependence with Dr. Iilun Murphy and Dr. Marta Sokolowska
		FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska
		Navigating the World of Online Pharmacies with CDR Lysette Deshields
		Expanded Access with Dr. Jacqueline Corrigan-Curay**January 16, 2024**

Drugs@FDA Data Files (Updated)
	Drug Trials Snapshot: POSLUMA
	FDA Drug Shortages
	Penicillin G Benzathine Injection (Updated - Currently in Shortage)
	Recomendaciones actualizadas de etiquetado de la FDA para productos biosimilares y biosimilares intercambiables
	Food and Drug Omnibus Report Act (FDORA) of 2022**January 12, 2024**

FDA approves pembrolizumab with chemoradiotherapy for FIGO 2014 Stage III-IVA cervical cancer
	FDA Drug Shortages
	Lisdexamfetamine Dimesylate Capsule (New - Currently in Shortage)**January 11, 2024**

Orange Book
	Approved Drug Products with Therapeutic Equivalence Evaluations
		Orange Book Current Cumulative Supplement (updated)
		Additions/Deletions for Prescription and OTC Drug Product Lists (updated)
		Orange Book Data Files (compressed) (updated)
		Appendix A: Product Name Index (updated)
			Appendix B: Product Name Sorted by Applicant (updated)
			Appendix C: Uniform Terms (updated)
		Reference Listed Drugs by ANDA Reference Standard List (updated)
		Orange Book Patent Listing Dispute List (updated)FDA Drug Shortages

	Lisdexamfetamine Dimesylate Capsule (New - Currently in Shortage)
	Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity
	Competitive Generic Therapy Approvals (updated)**January 10, 2024**

FDA Drug Shortages

	Penicillin G Benzathine Injection (New - Currently in Shortage)
	La FDA advierte a los consumidores de que no utilicen Ozempic (semaglutida) falsificado encontrado en la cadena de suministro de medicamentos de los EE.UU
	Medicamentos que contienen semaglutida comercializados para la diabetes de tipo 2 o la pérdida de peso**January 9, 2024**

Drugs@FDA Data Files (Updated)
	Drug Trials Snapshots: XENPOZYME
	FDA Drug Shortages
	Triamcinolone Acetonide Injection (Updated - Currently in Shortage)
		Valproate Sodium Injection (Updated - Discontinuation)**January 8, 2024**

Drug Trials Snapshots: KRAZATI
	FDA Drug Shortages
	Carboplatin Injection (New - Currently in Shortage)**January 2, 2024**

Drugs@FDA Data Files (Updated)
	Public Notifications:
	ENDUREA contains hidden drug ingredients
		ForeverMen contains hidden drug ingredient
		Seraphim Z contains hidden drug ingredient**December 29, 2023**

Coronavirus (COVID-19) | Medicamentos

                                                                                  Content current as of:
      01/30/2024
              
              
Regulated Product(s)
		 DrugsNews & Events for Human Drugs

          
                        CDER Conversations
          Q&A with FDA
          Spotlight on CDER Science


                        From Our Perspective
 SUBSCRIBE
                      Get regular FDA email updates delivered on this topic to your inbox.
    Enter your email address to subscribe:
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop